272 Results (Page 9 of 23)
All Free Sample Market Research Reports
Japan Electronic Health Records (EHR) Market Analysis Sample Report
Japan's electronic health record market size was valued at $2.26 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4% from 2022 to 2030 and will reach $3.09 Bn in 2030. Japan's EHR market growth can be attributed to the increasing adaptation of EHR by hospitals and clinics. The market is segmented by product type, application type, and end user. The key market players are Ujitsu, NEC, M3, NTT Data, and others.
Kenya Nutritional Supplements Market Analysis Sample Report
By 2030, it is anticipated that the Kenya Nutrition and Supplements market will reach a value of $xx Bn from $xx Bn Mn in 2022, growing at a CAGR of xx% during 2022-2030. The nutritional supplements market in Kenya is primarily dominated by local players such as Nutrivea, Healthwise Kenya, and Haltons Pharmacy. The market for nutrition and supplements in Kenya is primarily driven by an inclination towards better health infrastructure, government regulations and increasing consumer awareness of health and lifestyle. The Kenya nutrition and supplements market in Kenya is segmented by Type, Product, application, and Distribution Channel.
Australia Oral Care Market Analysis Sample Report
Australia's Oral Care market was valued at $423 Mn in 2022 and is estimated to expand at a CAGR of 7.7% from 2022 to 2030 and will reach $765 Mn in 2030. One of the main reasons propelling the growth of this market is Increasing Disposable Income and the ageing population. The market is segmented by type, drug, and distribution channel. Some key players in this market are White Glo, Grants of Australia, Red Seal, Dr. Brite, and Pure Smile among others.
Brazil Healthcare Insurance Market Analysis Sample Report
Brazil's healthcare insurance market is projected to grow from $50.66 Bn in 2022 to $98.01 Bn by 2030, registering a CAGR of 8.6% during the forecast period of 2022-2030. The main factors driving the growth would be increasing demand for private healthcare services, economic growth and rising income, regulatory reforms and technological advancements. The market is segmented by component, the provider, coverage, health insurance plans and end-user. Some of the major players include Bradesco Saude, Amil International Medical Assistance, Hapvida Sistema, Porto Seguro and Allianz.
Brazil Oncology Drugs Market Analysis Sample Report
By 2030, it is anticipated that the Brazil oncology drugs market will reach a value of $12.7 Bn from $4.9 Bn in 2022, growing at a CAGR of 12.6% during 2022-2030. The oncology drug market in Brazil is dominated by a few large pharmaceutical companies such as EMS Pharma, Eurofarma, and Takeda Pharma. The oncology market in Brazil is segmented by different therapeutic areas and by different treatment types. The major factors affecting the Brazilian oncology drugs market are the high cost of the drugs, and the structured reimbursement system for the treatment.
Canada Retail Pharmacy Market Analysis Sample Report
This report presents a strategic analysis of the Canada Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Canada Retail Pharmacy Market, offering unmatched value, accuracy and expert insights.
UAE Oncology Drugs Market Analysis Sample Report
By 2030, it is anticipated that the UAE oncology drugs market will reach a value of $2.54 Bn from $0.98 Bn in 2022, growing at a CAGR of 12.6% during 2022-2030. The oncology drug market in UAE is dominated by a few large pharmaceutical companies such as Biopharma Middle East & Africa, Neopharma Pharmaceutical Plant, and Newbridge Pharmaceuticals FZ LLC. The oncology market in UAE is segmented by different therapeutic areas, into breast cancer, lung cancer, colorectal cancer, prostate cancer, and others. The market is also segmented based on treatment types, such as surgery, radiation therapy, chemotherapy, and targeted therapy.
Egypt Nutritional Supplements Market Analysis Sample Report
By 2030, it is anticipated that the Egypt Nutrition and Supplements market will reach a value of $2.29 Bn from $1.07 Bn Mn in 2022, growing at a CAGR of 10% during 2022-2030. The nutritional supplements market in Egypt is primarily dominated by local players such as Amoun Pharmaceutical, Pharmed Healthcare, and EVA Pharma. The market for nutrition and supplements in the Egypt is primarily driven by an inclination towards better health infrastructure, government regulations and increasing consumer awareness of health and lifestyle. The Egypt nutrition and supplements market in Egypt is segmented by Type, Product, application, and Distribution Channel.
Egypt Clinical Diagnostics Market Analysis Sample Report
Egypt's clinical diagnostic market was valued at $193 Mn in 2022 and is estimated to expand at a CAGR of 7.5% from 2022-30 and will reach $344 Mn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Biomedica Egypt, Al Borg Laboratories, NileDiagnostic, Delta Medical, Abbott, BioMérieux, Danaher Corporation, Roche, Siemens Healthineers, Beckman Coulter, and others.
Mexico Medical and Diagnostic Laboratory Service Market Analysis Sample Report
This report presents a strategic analysis of the Mexico Medical and Diagnostic Laboratory Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Mexico Medical and Diagnostic Laboratory Service Market, offering unmatched value, accuracy and expert insights.
Mexico Nutritional Supplements Market Analysis Sample Report
Mexico's nutritional supplements market is projected to grow from $9.2 Mn in 2022 to $14.96 Mn by 2030, registering a CAGR of 7.4% during the forecast period of 2022-2030. The market for nutritional supplements in Mexico is a growing industry, with an increasing number of consumers seeking out products to support their health and wellness. The market is expected to continue to grow in the coming years, driven by factors such as an ageing population, increasing disposable incomes, and growing awareness of the importance of good nutrition. The key players in the Mexican nutritional supplements market include companies such as Herbalife, GNC, and Amway. Additionally, many local players such as FEMSA, Bimbo and Soriana also have a strong presence in the market.
Middle East Alzheimer’s Disease Drugs Market Analysis Sample Report
Middle East Alzheimer’s Disease Drugs market was valued at $617 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.42% from 2022 to 2030 and will reach $1267 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and government initiatives. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are Johnson and Johnson, Lupin Limited, Biogen Inc, Pfizer Inc, F. Hoffmann-La Roche AG, Novartis AG, Allergan Plc (acquired by Abbvie), Amarantus Bioscience Holdings Inc, and GE Healthcare.
